Sign In
NewsRadar

Search Press
Looking for press releases of a particular company? Enter company name (or keyword) here.

   


Green Biologics announces new Management Team appointments
Industry experts join as Chief Executive and Chief Operating Officer


Green Biologics Ltd (GBL), the Oxfordshire industrial biotechnology company developing renewable chemicals, today announced the appointments of Sean Sutcliffe as Chief Executive and Kristan Wadrop as Chief Operating Officer with immediate effect. Mr Sutcliffe succeeds founder and former CEO, Dr Edward Green, who becomes Chief Technical Officer.

Mr Sutcliffe, 44, joins GBL from Biofuels Corporation Trading Ltd, which operates one of Europe’s largest biodiesel plants, where he has been Chief Executive since 2005 and will retain a non-executive Chairman position. Mr Wadrop, 36, joins from Vireol plc, where he was responsible for technical and operational delivery including the project management of a £150 million bio-ethanol plant.

Last October, GBL secured £1.58 million from investors including Carbon Trust Investments and Oxford Capital Partners to develop its proprietary fermentation and process technology for the production of bio-butanol from waste feedstocks. Over the past six months, the Company has successfully completed investment milestones relating to the butanol process development, new patent filings, scale-up, commercial engagement and recruitment.

The efficiency of the fermentation process has been improved using Green Biologics’ novel proprietary microbes, resulting in significant cost reductions. Process improvements have been demonstrated at pilot plant scale in the Company’s laboratories at Milton Park, Oxfordshire, and GBL is now working with commercial partners to demonstrate its fermentation process on a larger scale.

The new appointments strengthen the management team to provide the technical, commercial and operational expertise necessary to commercialise and roll out GBL’s fermentation technology.

Chairman of GBL, Dr Andrew Rickman OBE, said: “We are making excellent progress with the development and successful demonstration of GBL’s bio-butanol fermentation process. We are collaborating with several crop processors to use low value and sustainable waste streams.

“Sean and Kristan bring extensive experience in the commercialisation and operational delivery of large scale biofuel programmes and complement Edward Green’s technology leadership as we move into the next stage of scale-up and demonstration. GBL is attracting a network of partners who are interested in collaborating on the production of bio-butanol utilising waste feedstocks as a viable alternative to petrochemicals and ‘first generation’ biofuels.”

Mr Sutcliffe said: “I look forward to working with Andrew, Edward and the other members of GBL’s management team. The Company has demonstrated that its unique advanced fermentation process for bio-butanol can work at pilot scale and I am excited by the opportunity to build on Edward’s work and lead a successful demonstration of the process on a significantly larger scale.”

Mr Wadrop said: “I am pleased to join GBL at this exciting stage of development. The Company’s bio-butanol product is unique in offering huge environmental and sustainability benefits, while being more cost-effective than conventional oil-derived chemical processes.”

Following these appointments, GBL has expanded to 25 staff at its Milton Park headquarters in Oxfordshire. GBL has also established offices and scale-up facilities in Georgia, USA.

- ENDS -
Press contact
Margaret Henry, PR Consultant. Tel: +44 (0)1865 811199 Email: m.henry@oxin.co.uk

Photos available on request
1. Welcoming the new additions to the GBL management team. L-R: Dr Edward Green (Founder and Chief Technical Officer), Sean Sutcliffe (the new Chief Executive), Dr Andrew Rickman OBE (Chairman), and Kristan Wadrop (the new Chief Operating Officer).

2. Head and shoulders photos of: Sean Sutcliffe, the new Chief Executive of GBL, and Kristan Wadrop, the new Chief Operating Officer of GBL.

3. Technology photos.

About Green Biologics
Green Biologics Ltd (GBL) is a leading industrial biotechnology<


Publisher Contact Information:

Green Biologics Limited (GBL)
+44 (0)1865 811199
m.henry@oxin.co.uk

Company profile of Green Biologics Limited (GBL)
Past press releases of Green Biologics Limited (GBL).

Data


26,016
Tech investments
From our Online Data Service
16,828
VC-backed companies
From our Radar


Recent Deals


DATEAMOUNTSECTOR
Aug 19€7.0MAgriculture related
Aug 19€9.0MInternet commerce
Aug 19€10.0ME-Commerce
Aug 19€63.0MBusiness applications
Aug 16€16.0ME-Commerce
Aug 16€6.0MBusiness applications
Aug 16N/ASoftware development

For information on Europe's most extensive database on technology funding click here!

Events



Press Releases


May 28
Identiq
identiq raises $5m seed, launches privacy-first identity validation...

Apr 29
Nethone
nethone raised over $1 million from innovation nest

Oct 1
The Link App
the link app launches version 2.0

Mar 29
Addex Therapeutics
addex sucessfully raises chf40 million in capital increase

Jan 2
Urban Jungle
urban jungle raises £1m in seed funding to build tech-enabled home ...





About usContact usLegal Information
Copyright © 1999-2019
Emerging Technology Research Europe Inc. All rights reserved.